Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 272 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 946. Clear
Clear
Q2
JAZZ PHARMACEUTICALS, INC. for JAZZ PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Pharmacy
View →
Q2
LUNDBECK LLC for LUNDBECK LLC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View →
Q2
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Pharmacy, Science/Technology, Trade (domestic/foreign)
View →
Q2
FEROX STRATEGIES for ALEXION PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Health Issues
View →
Q2
ALKERMES, INC. for ALKERMES, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate
Tariff (miscellaneous tariff bills), Medicare/Medicaid, Health Issues, Alcohol and Drug Abuse
View →
Q2
W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · $40,000.00 income
Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View →
Q2
W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate · $80,000.00 income
Medicare/Medicaid
View →
Q2
W STRATEGIES, LLC for INCYTE CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q2
THE NICKLES GROUP, LLC for AMGEN
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark, Taxation/Internal Revenue Code
View →
Q2
HEALTHCARE LEADERSHIP COUNCIL for HEALTHCARE LEADERSHIP COUNCIL
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid
View →
Q2
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
THE NICKLES GROUP, LLC for JOHNSON & JOHNSON SERVICES, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Bankruptcy
View →
Q2
THE NICKLES GROUP, LLC for MERCK & CO. INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues
View →
Q2
THE KPM GROUP DC LLC for INOZYME PHARMA
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $20,000.00 income
Pharmacy
View →
Q2
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q2
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q2
LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $20,000.00 income
Health Issues
View →
Q2
LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $30,000.00 income
Medicare/Medicaid
View →
Q2
LMH STRATEGIC SOLUTIONS for ALKERMES, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
RR
THE KPM GROUP DC LLC for INOZYME PHARMA
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts
Pharmacy
View →
Q2
THE NICKLES GROUP, LLC for UCB, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Georgia · House · Senate · $60,000.00 income
Medicare/Medicaid, Taxation/Internal Revenue Code, Health Issues, Trade (domestic/foreign)
View →
Q2
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate
Health Issues
View →
1A
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues
View →
Q1
TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Taxation/Internal Revenue Code, Trade (domestic/foreign), Defense
View →
Q1
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Insurance, Pharmacy
View →
Previous Page 9 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem